Search Results 31-40 of 14233 for remdesivir
The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...
The primary objective of this study is to evaluate whether remdesivir (RDV, GS-5734™) reduces the composite risk of death or invasive mechanical ventilation ( ...
Remdesivir needs to be administered intravenously daily for five days. Previously, patients who were otherwise ready for discharge might have remained in ...
... Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting. Rochester, Minn. The purpose of this study is to evaluate the effietiveness of remdesivir ...
Two antiviral drugs, called remdesivir and Paxlovid, are currently approved to treat COVID-19 . Researchers are evaluating many drugs and treatments for ...
But there are many other possible signs and symptoms. Currently, only one antiviral drug, called remdesivir, is approved to treat COVID-19. Some drugs may help ...
Each agent will be evaluated as add-on therapy to the standard of care (SoC) in accordance with national or local guidelines, which may include remdesivir.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.